What You Should Know:

您应该知道：

– PathAI, a leader in AI-powered digital pathology solutions, announced today the launch of AIM-MASH on its AISight Image Management System (IMS).

–人工智能数字病理解决方案的领导者PathAI今天宣布在其AISight图像管理系统（IMS）上推出AIM-MASH。

– The new product offers advanced AI-based measurement tools to support pathologists in assessing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) using the MASH Clinical Research Network (CRN) Activity Score.

–新产品提供了先进的基于人工智能的测量工具，以支持病理学家使用MASH临床研究网络（CRN）活动评分评估代谢功能障碍相关的脂肪变性肝病（MASLD）。

AIM-MASH Integration with AISight

AIM-MASH与AISight的集成

By integrating AIM-MASH with AISight, PathAI aims to improve the reproducibility, efficiency, and accuracy of MASH assessments. The AI-powered tools provide pathologists with valuable insights, including:

通过将AIM-MASH与AISight集成，PathAI旨在提高MASH评估的可重复性，效率和准确性。人工智能工具为病理学家提供了宝贵的见解，包括：

Highly sensitive and specific review: AI overlays highlight key areas for evaluation, reducing the risk of missed findings.Repeatable and reproducible assessments: AI algorithms improve consistency in scoring compared to manual methods.Increased scoring confidence: AI-generated data supports pathologists’ assessments and enhances accuracy.Global collaboration: AISight IMS enables remote review of cases by expert pathologists..

高度敏感和具体的审查：AI覆盖图突出了评估的关键领域，降低了遗漏发现的风险。可重复和可重复的评估：与手动方法相比，AI算法提高了评分的一致性。提高评分可信度：AI生成的数据支持病理学家的评估并提高准确性。全球合作：AISight IMS可由专家病理学家对病例进行远程审查。。

“We are thrilled to introduce AIM-MASH on the AISight IMS platform,” said Andy Beck, MD, PhD, CEO of PathAI. “This product is a game-changer for drug development, as it supports pathologists in making high-quality, reproducible MASH assessments. With AIM-MASH on AISight, pathologists can increase their confidence in pathology reads and decision-making, as if they have the world’s expert liver pathologists assisting with every slide, helping with simplifying the complex task of scoring and evaluation.”.

PathAI首席执行官、医学博士安迪·贝克（AndyBeck）表示：“我们很高兴在AISight IMS平台上推出AIM-MASH。”。“该产品是药物开发的游戏规则改变者，因为它支持病理学家进行高质量，可重复的MASH评估。通过AISight上的AIM-MASH，病理学家可以增加他们对病理阅读和决策的信心，就像他们有世界专家肝脏病理学家协助每张幻灯片一样，有助于简化评分和评估的复杂任务。”。